In 1975, the first class graduated from the then just five-year-old SIU School of Medicine. To look at the class photo, two things stand out for those of us looking at it with a 2017 gaze: in this small class of 24 people, there is only one person of color, and not one is female. The 1976 class, the charter class of the school, was significantly larger. The class of ’76 saw 43 graduates. Among those 43, there were no minorities, and just five women: Cris Anderson, MD, Brenda Baumann, MD, Regina Kovach, MD, Kathleen Link, MD, and Mary (Witges) Bengtson, MD. The charter women of SIU School of

The first time Jennifer Deiss ever took a Tylenol with codeine, also known as Tylenol 3, it was in 1983 when she was in her late twenties. Suffering from complications following surgery, doctors determined the now 62-year-old had arthritis that had been aggravated by bed rest. Her family doctor prescribed Tylenol 3 and a muscle relaxer. Today, with current CDC guidelines, that prescription would have an end date two to three weeks following surgery, no more. For Jennifer, that end date wouldn’t arrive for 34 years. The Fifth Vital Sign While there is no easy answer, one of the clear symptoms

The first time Jennifer Deiss ever took a Tylenol with codeine, also known as Tylenol 3, it was in 1983 when she was in her late twenties. Suffering from complications following surgery, doctors determined the now 62-year-old had arthritis that had been aggravated by bed rest. Her family doctor prescribed Tylenol 3 and a muscle relaxer. Today, with current CDC guidelines, that prescription would have an end date two to three weeks following surgery, no more. For Jennifer, that end date wouldn’t arrive for 34 years. The Fifth Vital Sign While there is no easy answer, one of the clear symptoms

The first time Jennifer Deiss ever took a Tylenol with codeine, also known as Tylenol 3, it was in 1983 when she was in her late twenties. Suffering from complications following surgery, doctors determined the now 62-year-old had arthritis that had been aggravated by bed rest. Her family doctor prescribed Tylenol 3 and a muscle relaxer. Today, with current CDC guidelines, that prescription would have an end date two to three weeks following surgery, no more. For Jennifer, that end date wouldn’t arrive for 34 years. The Fifth Vital Sign While there is no easy answer, one of the clear symptoms

The first time Jennifer Deiss ever took a Tylenol with codeine, also known as Tylenol 3, it was in 1983 when she was in her late twenties. Suffering from complications following surgery, doctors determined the now 62-year-old had arthritis that had been aggravated by bed rest. Her family doctor prescribed Tylenol 3 and a muscle relaxer. Today, with current CDC guidelines, that prescription would have an end date two to three weeks following surgery, no more. For Jennifer, that end date wouldn’t arrive for 34 years. The Fifth Vital Sign While there is no easy answer, one of the clear symptoms

As American lifespans increase due to progress made on other medical frontiers, the toll from Alzheimer’s disease (AD) grows. More than 5 million Americans are living with the disease, and by 2050 this number could rise as high as 16 million, according to the Alzheimer’s Association. The key to maintaining a functional quality of life resides in the recesses of the brain. A research scientist at Southern Illinois University Medicine has been awarded a $30,000 grant from the Illinois Department of Public Health’s Alzheimer’s Disease Research Fund to study brain energetics—the flow and

As American lifespans increase due to progress made on other medical frontiers, the toll from Alzheimer’s disease (AD) grows. More than 5 million Americans are living with the disease, and by 2050 this number could rise as high as 16 million, according to the Alzheimer’s Association. The key to maintaining a functional quality of life resides in the recesses of the brain. A research scientist at Southern Illinois University Medicine has been awarded a $30,000 grant from the Illinois Department of Public Health’s Alzheimer’s Disease Research Fund to study brain energetics—the flow and

As American lifespans increase due to progress made on other medical frontiers, the toll from Alzheimer’s disease (AD) grows. More than 5 million Americans are living with the disease, and by 2050 this number could rise as high as 16 million, according to the Alzheimer’s Association. The key to maintaining a functional quality of life resides in the recesses of the brain. A research scientist at Southern Illinois University Medicine has been awarded a $30,000 grant from the Illinois Department of Public Health’s Alzheimer’s Disease Research Fund to study brain energetics—the flow and

As American lifespans increase due to progress made on other medical frontiers, the toll from Alzheimer’s disease (AD) grows. More than 5 million Americans are living with the disease, and by 2050 this number could rise as high as 16 million, according to the Alzheimer’s Association. The key to maintaining a functional quality of life resides in the recesses of the brain. A research scientist at Southern Illinois University Medicine has been awarded a $30,000 grant from the Illinois Department of Public Health’s Alzheimer’s Disease Research Fund to study brain energetics—the flow and

Newsradio WJPF Interview with Dr. Sameer Vohra on July 5th, 2017